Biocartis Group N.V.

BIOGF · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Market Cap$37,319$227,723$208,432$225,005
- Cash$24,925$52,322$122,468$177,525
+ Debt$122,355$154,162$150,558$166,578
Enterprise Value$134,749$329,563$236,522$214,058
Revenue$57,481$48,269$43,128$37,444
% Growth19.1%11.9%15.2%
Gross Profit$27,682$14,347$16,844$16,116
% Margin48.2%29.7%39.1%43%
EBITDA-$43,953-$52,550-$43,230-$47,349
% Margin-76.5%-108.9%-100.2%-126.5%
Net Income-$65,381-$71,472-$62,934-$64,068
% Margin-113.7%-148.1%-145.9%-171.1%
EPS Diluted-1.08-1.24-1.11-1.14
% Growth12.9%-11.7%2.6%
Operating Cash Flow-$44,855-$65,716-$39,267-$54,254
Capital Expenditures-$1,937-$3,755-$3,020-$2,515
Free Cash Flow-$46,792-$69,471-$42,287-$56,769